Milrinone CAS:78415-72-2 CAS NO.78415-72-2
- FOB Price: USD: 1.00-1.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
in-house(25-1000)Kilogram
- Product Details
Keywords
- Milrinone Manufacturer
- 78415-72-2
- Milrinone producer
Quick Details
- ProName: Milrinone CAS:78415-72-2
- CasNo: 78415-72-2
- Molecular Formula: C12H9N3O
- Appearance: almost white powder
- Application: increase the heart's contractility and...
- DeliveryTime: prompt shipment
- PackAge: 25KG/DRUM
- Port: Any China port
- ProductionCapacity: 120 Metric Ton/Year
- Purity: 99%
- Storage: Preserve in tight, light-resistant con...
- Transportation: General cargo transport
- LimitNum: 1 Kilogram
Superiority
We are concentrating on APIs and pharmaceutical intermediates.
With in depth knowledge and understanding in this industry, we are indulged in supplying a wide assortments of Milrinone from Wuhan, Hubei, China.
It is made obtainable from us at the most reasonable rate.
Details
Year Establishment: 2009
Location: 18-1-802, Green Garden, Jianghan District, Wuhan 430023, China
Main product:
- API:Antiobesity; Oncology; Antiviral; Cardiovascular; Antibiotics; Antidiabetics and others
- Peptides
- Hormones
- Intermediates
Feature:
Product name |
Milrinone |
Synonyms |
3-CYANO-6-METHYL-5-(4-PYRIDYL)-2-PYRIDONE; 6-METHYL-5-(4-PYRIDYL)-2-PYRIDONE-3-CARBONITRILE; 1,6-DIHYDRO-2-METHYL-6-OXO-(3,4'-BIPYRIDINE)-5-CARBONITRILE; 1,6-DIHYDRO-2-METHYL-6-OXO-3,4-BIPYRIDINE-5-CARBONITRILe; 1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)-NICOTINONITRILE |
MOQ |
25KG |
CAS No. |
78415-72-2 |
Appearance |
An almost white powder |
Molecular Formula |
C12H9N3O |
Molecular Weight |
211.22 |
Assay |
99% |
Application |
Pharma grade or research purpose |
Packing |
As per your request |
Storage |
Preserve in tight, light-resistant containers in a cool place |
Remarks |
NA |
Custom synthesis |
Available |
Supply Ability |
10000kg/month |
Medical use:
Milrinone is a medication used in patients who have heart failure. It is a phosphodiesterase 3 inhibitor that works to increase the heart's contractility and decrease pulmonary vascular resistance. Milrinone also works to vasodilate which helps alleviate increased pressures (afterload) on the heart, thus improving its pumping action. While it has been used in people with heart failure for many years, studies suggest that milrinone may exhibit some negative side effects that have caused some debate about its use clinically.
Overall, milrinone supports ventricular functioning of the heart by decreasing the degradation of cAMP and thus increasing phosphorylation levels of many components in the heart that contribute to contractility and heart rate. Milrinone use following cardiac surgery has been under some debate because of the potential increase risk of postoperative atrial arrhythmias. However, in the short term milrinone has been deemed beneficial to those experiencing heart failure and an effective therapy to maintain heart function following cardiac surgeries. There is no evidence of any long term beneficial effects on survival. In critically ill patients with evidence of cardiac dysfunction there is limited good quality evidence to recommend its use.
Package: